[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Biologics & Biosimilars Market Research Report 2018

June 2018 | 107 pages | ID: GA3E665E157EN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies the global Biologics & Biosimilars market status and forecast, categorizes the global Biologics & Biosimilars market size (value & volume) by key players, type, application, and region.
This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The global Biologics & Biosimilars market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

The major manufacturers covered in this report
  • fizer
  • Roche
  • Amgen
  • AbbVie
  • Sanofi
  • Johnson & Johnson
  • Novo Nordisk
  • Novartis
  • Merck
  • Lilly
  • 3sbio
  • Changchun High Tech
  • CP Guojian Pharmacy
  • Biotech Pharma
  • Gelgen Biopharma
  • Sandoz
  • Teva
  • Hospira
  • Mylan
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
We can also provide the customized separate regional or country-level reports, for the following regions:
  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Singapore
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Central & South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • Turkey
    • Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Antibiotic
  • Enzyme
  • Hormone
  • Non-Patented Biological Reagents
  • Other
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
  • Tumor
  • Diabetes
  • Cardiovascular
  • Hemophilia
  • Other
The study objectives of this report are:
  • To analyze and study the global Biologics & Biosimilars sales, value, status (2013-2017) and forecast (2018-2025).
  • Focuses on the key Biologics & Biosimilars manufacturers, to study the sales, value, market share and development plans in future.
  • Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Biologics & Biosimilars are as follows:
  • History Year: 2013-2017
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Biologics & Biosimilars Manufacturers
Biologics & Biosimilars Distributors/Traders/Wholesalers
Biologics & Biosimilars Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Biologics & Biosimilars market, by end-use.
Detailed analysis and profiles of additional market players.
Global Biologics & Biosimilars Market Research Report 2018

1 BIOLOGICS & BIOSIMILARS MARKET OVERVIEW

1.1 Product Overview and Scope of Biologics & Biosimilars
1.2 Biologics & Biosimilars Segment by Type (Product Category)
  1.2.1 Global Biologics & Biosimilars Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
  1.2.2 Global Biologics & Biosimilars Production Market Share by Type (Product Category) in 2017
  1.2.3 Antibiotic
  1.2.4 Enzyme
  1.2.5 Hormone
  1.2.6 Non-Patented Biological Reagents
  1.2.7 Other
1.3 Global Biologics & Biosimilars Segment by Application
  1.3.1 Biologics & Biosimilars Consumption (Sales) Comparison by Application (2013-2025)
  1.3.2 Tumor
  1.3.3 Diabetes
  1.3.4 Cardiovascular
  1.3.5 Hemophilia
  1.3.6 Other
1.4 Global Biologics & Biosimilars Market by Region (2013-2025)
  1.4.1 Global Biologics & Biosimilars Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
  1.4.2 North America Status and Prospect (2013-2025)
  1.4.3 Europe Status and Prospect (2013-2025)
  1.4.4 China Status and Prospect (2013-2025)
  1.4.5 Japan Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Status and Prospect (2013-2025)
  1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Biologics & Biosimilars (2013-2025)
  1.5.1 Global Biologics & Biosimilars Revenue Status and Outlook (2013-2025)
  1.5.2 Global Biologics & Biosimilars Capacity, Production Status and Outlook (2013-2025)

2 GLOBAL BIOLOGICS & BIOSIMILARS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Biologics & Biosimilars Capacity, Production and Share by Manufacturers (2013-2018)
  2.1.1 Global Biologics & Biosimilars Capacity and Share by Manufacturers (2013-2018)
  2.1.2 Global Biologics & Biosimilars Production and Share by Manufacturers (2013-2018)
2.2 Global Biologics & Biosimilars Revenue and Share by Manufacturers (2013-2018)
2.3 Global Biologics & Biosimilars Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Biologics & Biosimilars Manufacturing Base Distribution, Sales Area and Product Type
2.5 Biologics & Biosimilars Market Competitive Situation and Trends
  2.5.1 Biologics & Biosimilars Market Concentration Rate
  2.5.2 Biologics & Biosimilars Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL BIOLOGICS & BIOSIMILARS CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2013-2018)

3.1 Global Biologics & Biosimilars Capacity and Market Share by Region (2013-2018)
3.2 Global Biologics & Biosimilars Production and Market Share by Region (2013-2018)
3.3 Global Biologics & Biosimilars Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Biologics & Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Biologics & Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Biologics & Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Biologics & Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Biologics & Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Biologics & Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Biologics & Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 GLOBAL BIOLOGICS & BIOSIMILARS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2013-2018)

4.1 Global Biologics & Biosimilars Consumption by Region (2013-2018)
4.2 North America Biologics & Biosimilars Production, Consumption, Export, Import (2013-2018)
4.3 Europe Biologics & Biosimilars Production, Consumption, Export, Import (2013-2018)
4.4 China Biologics & Biosimilars Production, Consumption, Export, Import (2013-2018)
4.5 Japan Biologics & Biosimilars Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Biologics & Biosimilars Production, Consumption, Export, Import (2013-2018)
4.7 India Biologics & Biosimilars Production, Consumption, Export, Import (2013-2018)

5 GLOBAL BIOLOGICS & BIOSIMILARS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Biologics & Biosimilars Production and Market Share by Type (2013-2018)
5.2 Global Biologics & Biosimilars Revenue and Market Share by Type (2013-2018)
5.3 Global Biologics & Biosimilars Price by Type (2013-2018)
5.4 Global Biologics & Biosimilars Production Growth by Type (2013-2018)

6 GLOBAL BIOLOGICS & BIOSIMILARS MARKET ANALYSIS BY APPLICATION

6.1 Global Biologics & Biosimilars Consumption and Market Share by Application (2013-2018)
6.2 Global Biologics & Biosimilars Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL BIOLOGICS & BIOSIMILARS MANUFACTURERS PROFILES/ANALYSIS

7.1 fizer
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Biologics & Biosimilars Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 fizer Biologics & Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.1.4 Main Business/Business Overview
7.2 Roche
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Biologics & Biosimilars Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Roche Biologics & Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.2.4 Main Business/Business Overview
7.3 Amgen
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Biologics & Biosimilars Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Amgen Biologics & Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.3.4 Main Business/Business Overview
7.4 AbbVie
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Biologics & Biosimilars Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 AbbVie Biologics & Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.4.4 Main Business/Business Overview
7.5 Sanofi
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Biologics & Biosimilars Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Sanofi Biologics & Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
  7.5.4 Main Business/Business Overview
7.6 Johnson & Johnson
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Biologics & Biosimilars Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Johnson & Johnson Biologics & Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.6.4 Main Business/Business Overview
7.7 Novo Nordisk
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Biologics & Biosimilars Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Novo Nordisk Biologics & Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.7.4 Main Business/Business Overview
7.8 Novartis
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Biologics & Biosimilars Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Novartis Biologics & Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.8.4 Main Business/Business Overview
7.9 Merck
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Biologics & Biosimilars Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Merck Biologics & Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.9.4 Main Business/Business Overview
7.10 Lilly
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Biologics & Biosimilars Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Lilly Biologics & Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2020)
  7.10.4 Main Business/Business Overview
7.11 3sbio
7.12 Changchun High Tech
7.13 CP Guojian Pharmacy
7.14 Biotech Pharma
7.15 Gelgen Biopharma
7.16 Sandoz
7.17 Teva
7.18 Hospira
7.19 Mylan

8 BIOLOGICS & BIOSIMILARS MANUFACTURING COST ANALYSIS

8.1 Biologics & Biosimilars Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Biologics & Biosimilars

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Biologics & Biosimilars Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Biologics & Biosimilars Major Manufacturers in 2017
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL BIOLOGICS & BIOSIMILARS MARKET FORECAST (2018-2025)

12.1 Global Biologics & Biosimilars Capacity, Production, Revenue Forecast (2018-2025)
  12.1.1 Global Biologics & Biosimilars Capacity, Production and Growth Rate Forecast (2018-2025)
  12.1.2 Global Biologics & Biosimilars Revenue and Growth Rate Forecast (2018-2025)
  12.1.3 Global Biologics & Biosimilars Price and Trend Forecast (2018-2025)
12.2 Global Biologics & Biosimilars Production, Consumption, Import and Export Forecast by Region (2018-2025)
  12.2.1 North America Biologics & Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.2 Europe Biologics & Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.3 China Biologics & Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.4 Japan Biologics & Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.5 Southeast Asia Biologics & Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.6 India Biologics & Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Biologics & Biosimilars Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Biologics & Biosimilars Consumption Forecast by Application (2018-2025)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Biologics & Biosimilars
Figure Global Biologics & Biosimilars Production () and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Biologics & Biosimilars Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Antibiotic
Table Major Manufacturers of Antibiotic
Figure Product Picture of Enzyme
Table Major Manufacturers of Enzyme
Figure Product Picture of Hormone
Table Major Manufacturers of Hormone
Figure Product Picture of Non-Patented Biological Reagents
Table Major Manufacturers of Non-Patented Biological Reagents
Figure Product Picture of Other
Table Major Manufacturers of Other
Figure Global Biologics & Biosimilars Consumption (K Units) by Applications (2013-2025)
Figure Global Biologics & Biosimilars Consumption Market Share by Applications in 2017
Figure Tumor Examples
Table Key Downstream Customer in Tumor
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure Hemophilia Examples
Table Key Downstream Customer in Hemophilia
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Biologics & Biosimilars Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2013-2025)
Figure North America Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Biologics & Biosimilars Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Biologics & Biosimilars Capacity, Production (K Units) Status and Outlook (2013-2025)
Figure Global Biologics & Biosimilars Major Players Product Capacity (K Units) (2013-2018)
Table Global Biologics & Biosimilars Capacity (K Units) of Key Manufacturers (2013-2018)
Table Global Biologics & Biosimilars Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Biologics & Biosimilars Capacity (K Units) of Key Manufacturers in 2017
Figure Global Biologics & Biosimilars Capacity (K Units) of Key Manufacturers in 2018
Figure Global Biologics & Biosimilars Major Players Product Production (K Units) (2013-2018)
Table Global Biologics & Biosimilars Production (K Units) of Key Manufacturers (2013-2018)
Table Global Biologics & Biosimilars Production Share by Manufacturers (2013-2018)
Figure 2017 Biologics & Biosimilars Production Share by Manufacturers
Figure 2017 Biologics & Biosimilars Production Share by Manufacturers
Figure Global Biologics & Biosimilars Major Players Product Revenue (Million USD) (2013-2018)
Table Global Biologics & Biosimilars Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Biologics & Biosimilars Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Biologics & Biosimilars Revenue Share by Manufacturers
Table 2018 Global Biologics & Biosimilars Revenue Share by Manufacturers
Table Global Market Biologics & Biosimilars Average Price (USD/Unit) of Key Manufacturers (2013-2018)
Figure Global Market Biologics & Biosimilars Average Price (USD/Unit) of Key Manufacturers in 2017
Table Manufacturers Biologics & Biosimilars Manufacturing Base Distribution and Sales Area
Table Manufacturers Biologics & Biosimilars Product Category
Figure Biologics & Biosimilars Market Share of Top 3 Manufacturers
Figure Biologics & Biosimilars Market Share of Top 5 Manufacturers
Table Global Biologics & Biosimilars Capacity (K Units) by Region (2013-2018)
Figure Global Biologics & Biosimilars Capacity Market Share by Region (2013-2018)
Figure Global Biologics & Biosimilars Capacity Market Share by Region (2013-2018)
Figure 2017 Global Biologics & Biosimilars Capacity Market Share by Region
Table Global Biologics & Biosimilars Production by Region (2013-2018)
Figure Global Biologics & Biosimilars Production (K Units) by Region (2013-2018)
Figure Global Biologics & Biosimilars Production Market Share by Region (2013-2018)
Figure 2017 Global Biologics & Biosimilars Production Market Share by Region
Table Global Biologics & Biosimilars Revenue (Million USD) by Region (2013-2018)
Table Global Biologics & Biosimilars Revenue Market Share by Region (2013-2018)
Figure Global Biologics & Biosimilars Revenue Market Share by Region (2013-2018)
Table 2017 Global Biologics & Biosimilars Revenue Market Share by Region
Figure Global Biologics & Biosimilars Capacity, Production (K Units) and Growth Rate (2013-2018)
Table Global Biologics & Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table North America Biologics & Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Europe Biologics & Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table China Biologics & Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Japan Biologics & Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table China Biologics & Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Japan Biologics & Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Global Biologics & Biosimilars Consumption (K Units) Market by Region (2013-2018)
Table Global Biologics & Biosimilars Consumption Market Share by Region (2013-2018)
Figure Global Biologics & Biosimilars Consumption Market Share by Region (2013-2018)
Figure 2017 Global Biologics & Biosimilars Consumption (K Units) Market Share by Region
Table North America Biologics & Biosimilars Production, Consumption, Import & Export (K Units) (2013-2018)
Table Europe Biologics & Biosimilars Production, Consumption, Import & Export (K Units) (2013-2018)
Table China Biologics & Biosimilars Production, Consumption, Import & Export (K Units) (2013-2018)
Table Japan Biologics & Biosimilars Production, Consumption, Import & Export (K Units) (2013-2018)
Table Southeast Asia Biologics & Biosimilars Production, Consumption, Import & Export (K Units) (2013-2018)
Table India Biologics & Biosimilars Production, Consumption, Import & Export (K Units) (2013-2018)
Table Global Biologics & Biosimilars Production (K Units) by Type (2013-2018)
Table Global Biologics & Biosimilars Production Share by Type (2013-2018)
Figure Production Market Share of Biologics & Biosimilars by Type (2013-2018)
Figure 2017 Production Market Share of Biologics & Biosimilars by Type
Table Global Biologics & Biosimilars Revenue (Million USD) by Type (2013-2018)
Table Global Biologics & Biosimilars Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Biologics & Biosimilars by Type (2013-2018)
Figure 2017 Revenue Market Share of Biologics & Biosimilars by Type
Table Global Biologics & Biosimilars Price (USD/Unit) by Type (2013-2018)
Figure Global Biologics & Biosimilars Production Growth by Type (2013-2018)
Table Global Biologics & Biosimilars Consumption (K Units) by Application (2013-2018)
Table Global Biologics & Biosimilars Consumption Market Share by Application (2013-2018)
Figure Global Biologics & Biosimilars Consumption Market Share by Applications (2013-2018)
Figure Global Biologics & Biosimilars Consumption Market Share by Application in 2017
Table Global Biologics & Biosimilars Consumption Growth Rate by Application (2013-2018)
Figure Global Biologics & Biosimilars Consumption Growth Rate by Application (2013-2018)
Table fizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table fizer Biologics & Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (fizer) and Gross Margin (2013-2018)
Figure fizer Biologics & Biosimilars Production Growth Rate (2013-2018)
Figure fizer Biologics & Biosimilars Production Market Share (2013-2018)
Figure fizer Biologics & Biosimilars Revenue Market Share (2013-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Biologics & Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Roche Biologics & Biosimilars Production Growth Rate (2013-2018)
Figure Roche Biologics & Biosimilars Production Market Share (2013-2018)
Figure Roche Biologics & Biosimilars Revenue Market Share (2013-2018)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Biologics & Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Biologics & Biosimilars Production Growth Rate (2013-2018)
Figure Amgen Biologics & Biosimilars Production Market Share (2013-2018)
Figure Amgen Biologics & Biosimilars Revenue Market Share (2013-2018)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Biologics & Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AbbVie Biologics & Biosimilars Production Growth Rate (2013-2018)
Figure AbbVie Biologics & Biosimilars Production Market Share (2013-2018)
Figure AbbVie Biologics & Biosimilars Revenue Market Share (2013-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Biologics & Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Biologics & Biosimilars Production Growth Rate (2013-2018)
Figure Sanofi Biologics & Biosimilars Production Market Share (2013-2018)
Figure Sanofi Biologics & Biosimilars Revenue Market Share (2013-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Biologics & Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson Biologics & Biosimilars Production Growth Rate (2013-2018)
Figure Johnson & Johnson Biologics & Biosimilars Production Market Share (2013-2018)
Figure Johnson & Johnson Biologics & Biosimilars Revenue Market Share (2013-2018)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Biologics & Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novo Nordisk Biologics & Biosimilars Production Growth Rate (2013-2018)
Figure Novo Nordisk Biologics & Biosimilars Production Market Share (2013-2018)
Figure Novo Nordisk Biologics & Biosimilars Revenue Market Share (2013-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Biologics & Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Biologics & Biosimilars Production Growth Rate (2013-2018)
Figure Novartis Biologics & Biosimilars Production Market Share (2013-2018)
Figure Novartis Biologics & Biosimilars Revenue Market Share (2013-2018)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Biologics & Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck Biologics & Biosimilars Production Growth Rate (2013-2018)
Figure Merck Biologics & Biosimilars Production Market Share (2013-2018)
Figure Merck Biologics & Biosimilars Revenue Market Share (2013-2018)
Table Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lilly Biologics & Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Lilly Biologics & Biosimilars Production Growth Rate (2013-2018)
Figure Lilly Biologics & Biosimilars Production Market Share (2013-2018)
Figure Lilly Biologics & Biosimilars Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologics & Biosimilars
Figure Manufacturing Process Analysis of Biologics & Biosimilars
Figure Biologics & Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biologics & Biosimilars Major Manufacturers in 2017
Table Major Buyers of Biologics & Biosimilars
Table Distributors/Traders List
Figure Global Biologics & Biosimilars Capacity, Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Biologics & Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Biologics & Biosimilars Price (Million USD) and Trend Forecast (2018-2025)
Table Global Biologics & Biosimilars Production (K Units) Forecast by Region (2018-2025)
Figure Global Biologics & Biosimilars Production Market Share Forecast by Region (2018-2025)
Table Global Biologics & Biosimilars Consumption (K Units) Forecast by Region (2018-2025)
Figure Global Biologics & Biosimilars Consumption Market Share Forecast by Region (2018-2025)
Figure North America Biologics & Biosimilars Production (K Units) and Growth Rate Forecast (2018-2025)
Figure North America Biologics & Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Biologics & Biosimilars Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Europe Biologics & Biosimilars Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Biologics & Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Biologics & Biosimilars Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure China Biologics & Biosimilars Production (K Units) and Growth Rate Forecast (2018-2025)
Figure China Biologics & Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table China Biologics & Biosimilars Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Japan Biologics & Biosimilars Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Biologics & Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Japan Biologics & Biosimilars Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Southeast Asia Biologics & Biosimilars Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Biologics & Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Biologics & Biosimilars Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure India Biologics & Biosimilars Production (K Units) and Growth Rate Forecast (2018-2025)
Figure India Biologics & Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Biologics & Biosimilars Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Table Global Biologics & Biosimilars Production (K Units) Forecast by Type (2018-2025)
Figure Global Biologics & Biosimilars Production (K Units) Forecast by Type (2018-2025)
Table Global Biologics & Biosimilars Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Biologics & Biosimilars Revenue Market Share Forecast by Type (2018-2025)
Table Global Biologics & Biosimilars Price Forecast by Type (2018-2025)
Table Global Biologics & Biosimilars Consumption (K Units) Forecast by Application (2018-2025)
Figure Global Biologics & Biosimilars Consumption (K Units) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source


More Publications